Ayman Alabdallah

Ayman AlAbdallah serves as a Partner at Mubadala Capital since 2018, managing a diverse portfolio that includes technology and biotech investments. Notable companies in the portfolio include Capital Rx, Ciitizen, Iambic, and IonQ, with Ayman taking board roles in several firms. Prior experience includes positions as Senior Associate in Corporate Development at Tecan, focusing on M&A, and as an Event-Driven Investing Post-MBA Intern at OMERS Capital Markets. Additional roles include MBA Fellow at Airo Health, internships in corporate development at Tecan and engineering at Sentinelle Medical, and management consulting with Accenture. Ayman holds a Bachelor of Applied Science in Mechanical Engineering and a Master of Business Administration from the University of Toronto.